The pneumococcal surface adhesin A (PsaA) protein and its application in conjugate vaccine
10.3760/cma.j.issn.0254-5101.2011.07.017
- VernacularTitle:肺炎球菌PsaA抗原及其在结合疫苗中的应用
- Author:
Xiaoying FAN
;
Honggang XUE
;
Rong GUO
;
Jing HU
;
Jiali LU
;
Yuexiong ZHU
- Publication Type:Journal Article
- Keywords:
PsaA;
CAMP;
Conjugate;
Bivalent conjugates
- From:
Chinese Journal of Microbiology and Immunology
2011;31(7):647-652
- CountryChina
- Language:Chinese
-
Abstract:
Objective To express and purify the pneumococcal surface adhesin A(PsaA) protein,discuss its application as a protein carrier in conjugates vaccine. Methods The gene encoding for the PsaA protein was amplified from the genomic DNA of Streptococcus pneumoniae using PCR. The PCR product was then cloned into the prokaryotic expression vector pET-28a and the recombinant was transformed into host cell E. coli BL21 (DE3). The expression of the recombinant protein(rPsaA) was induced by IPTG and purifled by using DEAE anion-exchange chromatography. The rPsaA was successfully conjugated with group A meningococcal polysaccharide(GAMP). The mice were immunized subcutaneously with the conjugate and the immune responses against GAMP and PsaA were detected by ELISA. Results The recombinant PsaA was expressed as a 37 × 103 soluble protein without His-Tag. The rPsaA was successfully conjugated with GAMP. In addition to the immune response against PsaA, The antibody response against GAMP was significant improved in the mice immunized with conjugate vaccine in comparison with those immunized with GAMP alone. Conclusion The recombinant protein PsaA without His-Tag was obtained and conjugated with GAMP. The strong antibody responses against PsaA and CAMP were obtained in the immunized mice at the same time which may provide the protection against pneumonia and meningitis simultaneously.
